Hadassah Stem Cell Expert Speaks at TEDx Conference in Jaffa
Prof. Tamir Ben-Hur, the Hadassah Medical Organization’s world-renowned neurologist and stem cell research specialist, gave a presentation entitled “Stem Cells: Protectors of the Brain” at the 2014 TEDx conference, held at the Peres Center for Peace in Jaffa, Israel.
FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease
A new drug technology, developed at the Hadassah Medical Organization to treat fatty liver disease--a condition with no approved effective drug treatment--was given the go-ahead by the United States Food and Drug Administration (FDA) for a Phase 2 multi-center clinical trial in the US.
New Research at Hadassah: Computational Tools Unravel the Mystery of Transient Amnesia
Hadassah Medical Organization researchers have identified what happens physiologically during transient global amnesia (TGA), an episodic, rapid-onset amnesia that is characterized by a person’s impaired ability to retrieve and create newer memories, along with temporal disorientation and repetitive questioning that lasts up to 24 hours. The study findings were published in the May issue of the prestigious journal, Annals of Neurology (Volume 75, pages 634-643) and highlighted on the cover.
From Life-Threatening Brain Bleed to Birth of a Daughter
When Gila Sibony was six months pregnant, she suffered a life-threatening bleed in her brain. The Hadassah Medical Organization’s specialists saved her life, but she lost the baby.
Fast forward about five years and Gila is the mother of a new baby girl, born at Hadassah.
Cookbook Author, Rabbi Marks, Spends Last Days at Hadassah's Hospice
"We knew his time was limited, and his dying became inevitable, so we asked for a place in the Hadassah hospice on Mount Scopus,” relates Sharon Altshul, speaking of her brother, Rabbi Gil Marks. “We wanted a dignified and compassionate place,” she said. “And that's what we found.”
Hadassah’s Revolutionary Tipat Halav Clinics of 1920s Featured in Jerusalem Old City Museum
The black and white photo at the entrance to the museum is from Hadassah’s Old City Tipat Halav Collection, documenting life in the 1920’s. It was at the well-baby clinics that pasteurized milk was distributed to the mothers of the city, bringing a revolutionary upgrade to mother and child health and nutrition.
Victims of Terror Share Their Stories of Anguish and Appreciation with Hadassah President
Hadassah National President Marcie Natan and Barbara Sofer, Israel Public Relations Director for Hadassah, visited victims of terror in the Hadassah Medical Center’s intensive care units and the Sarah Wetsman Davidson (SWD) Hospital Tower.
Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan
The Hadassah Medical Organization, using the powerful research tool of advanced gene sequencing, has identified a gene mutation that 3 of a couple’s 12 children shared, which caused them to have an intellectual disability, short stature, seizures, and disturbed glucose metabolism. Now the other healthy children are able to be tested to see if they carry the mutation and to plan their futures.
IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah
“When I saw a young woman on the road, I stopped my car,” relates Yishayahu Horowitz, a medic in the Israel Defense Forces. “At first I thought it was a car accident, but then I realized it was a terror attack.
On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research
“Today we are seeing a revolution in the treatment of melanoma and the Hadassah Medical Center is among the world leaders because we always believed that the immune system can combat cancer,” says Dr. Michal Lotem, head of Hadassah’s Organization for Melanoma and Cancer Immunotherapy.
“He was two and a half months old when I saw him for the first time,” said Hadassah Medical Organization Pediatric Ophthalmologist Dr. Irene Anteby about the East Jerusalem baby who was assumed to be blind. Dr. Anteby, however, realized he wasn’t reacting to light because dense cataracts were blocking his vision.
Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA
Jerusalem’s Cell Cure Neurosciences, whose mission is to become a leading supplier of human cell-based therapies for the treatment of retinal and neurodegenerative diseases, has received approval from the United States Food and Drug Administration (FDA) to conduct a clinical trial to treat the dry form of age-related macular degeneration (AMD) with OpRegen®, a first-of-its kind animal product-free, retinal pigment epithelial (RPE) cell formulation derived from human embryonic stem cells (hESCs).
“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient
Active and independent, doing her own shopping and cooking along with volunteer work in the West Bank city of Bethlehem, 82-year-old Maria suddenly collapsed after she stopped taking her blood thinner to prepare for a dental procedure.
Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General
Describing the Hadassah Medical Organization’s new inpatient facility— the Sarah Wetsman Davidson Hospital Tower— as “a beacon of healing that rises from the Jerusalem hillside,” Acting Director General Prof. Tamar Peretz explained to her New York audience of supporters that “a steering committee of people on both sides of the ocean worked together to plan the best hospital building in the world.”
Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program
Keynoting the colorful 39th graduation ceremony of the International Master of Public Health (IMPH) program of the Hadassah-Hebrew University’s Braun School of Public Health and Community Medicine was 1999 IMPH graduate, Dr. Anna Marzec-Boguslawska, Director of The National AIDS Center, Warsaw, Poland. Her topic was: "Bringing it All Together: Building on the IMPH experience for effective responses to public health threats in an ever-changing world.”
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>